Health ❯ Clinical Research

Drug Trials

Patient Outcomes Animal Studies Mouse Models Phase II Studies GLP-1 Agonists Polypill Studies Omalizumab Drug Trials Omalizumab (Xolair) Trials Adverse Effects Antibiotic Efficacy Laboratory Studies Neurodevelopmental Disorders Phase 1 Trials Human Studies Phase 3 Trials Anti-Amyloid Therapies Efficacy Studies Cannabis Studies Participant Enrollment Adjuvant Therapy Regulatory Approval Compassionate Use Pipeline Development Late-Stage Trials

argenx Posts $1.52 Billion Quarter as VYVGART Readouts Loom

The jump in sales boosts the company's cash and lets it fund near-term registrational trials that could broaden VYVGART's approved uses.

Biogen, Dayra Launch $50 Million Pact to Develop Oral Macrocyclic Peptides for Immunology

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

Bristol Myers’ Iberdomide Combo Hits MRD Goal in Phase 3 Myeloma Study

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer